All sites C00-96,D32-33,D42-43,D45-47,D76 1400 89.5 1.4 4.0 1.2 4.0
Mouth, pharynx C00-14 23 98.3 0.9 0.9 - -
  Lip C00 4 94.7 - 5.3 - -
  Tongue C02 7 100.0 - - - -
  Mouth, other C03-06 6 100.0 - - - -
  Salivary glands C07-08 2 90.9 9.1 - - -
  Pharynx C01,C09-14 4 100.0 - - - -
Digestive organs C15-26 259 75.8 0.5 13.1 2.9 7.6
  Oesophagus C15 9 93.0 - 4.7 - 2.3
  Stomach C16 26 93.9 - 1.5 0.8 3.8
  Small intestine C17 4 88.9 - 11.1 - -
  Colon C18 94 93.2 - 2.1 1.1 3.6
  Rectum, rectosigmoid C19-20 36 97.8 - 1.1 - 1.1
  Anus C21 2 100.0 - - - -
  Liver C22 16 63.3 3.8 16.5 10.1 6.3
  Gallbladder, bile ducts C23-24 14 41.2 2.9 38.2 2.9 14.7
  Pancreas C25 55 36.9 0.7 39.1 5.5 17.9
  Other digestive organs C26 6 17.9 - 21.4 25.0 35.7
Respiratory organs C30-39 86 76.9 7.6 7.4 2.1 6.0
  Nose, sinuses C30-31 1 100.0 - - - -
  Larynx, epiglottis C32 2 100.0 - - - -
  Lung, trachea C33-34 81 76.8 8.1 7.7 1.7 5.7
  Mediastinum, pleura C38 1 66.7 - 33.3 - -
Bone C40-41 1 83.3 - - - 16.7
Melanoma of the skin C43 59 100.0 - - - -
Skin, non-melanoma C44 72 100.0 - - - -
Mesothelioma C45 2 100.0 - - - -
Autonomic nervous system C47 0 100.0 - - - -
Soft tissues C48-49 10 95.8 - 2.1 - 2.1
Breast C50 451 99.5 0.1 0.1 0.1 0.2
Female genital organs C51-58 145 94.5 0.6 2.1 1.0 1.9
  Cervix uteri C53 10 98.0 2.0 - - -
  Corpus uteri C54 73 98.9 0.3 0.3 0.3 0.3
  Uterus, other C55,C58 1 33.3 - 66.7 - -
  Ovary C56 45 89.2 0.4 5.4 0.9 4.0
  Other female genital C51-52,C57 17 89.2 1.2 - 4.8 4.8
Urinary organs C64-68 61 86.6 1.3 5.2 2.3 4.6
  Kidney C64 39 83.4 - 7.8 3.1 5.7
  Bladder and urinary tract2 C65-68 23 92.1 3.5 0.9 0.9 2.6
Eye C69 1 66.7 - 16.7 - 16.7
Brain, central nervous system C70-72,D32-33,D42-43 59 90.5 - 3.0 1.4 5.1
Thyroid gland C73 21 95.3 4.7 - - -
Other endocrine glands C74-75 0 50.0 - - 50.0 -
Illdefined or unknown C76,C80 34 50.9 7.1 15.4 5.3 21.3
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 114 81.0 4.9 1.1 1.1 12.0
  Hodgkin lymphoma C81 7 97.3 - - - 2.7
  Non-Hodgkin lymphoma C82-86,C96,D76 45 97.3 - - 0.4 2.2
  Malignant immunoproliferative diseases C88 1 80.0 - - - 20.0
  Myeloma and other plasma cell tumors C90 14 71.8 5.6 8.5 1.4 12.7
  Leukaemia C91-95 25 66.1 12.1 - 1.6 20.2
  Myelodysplastic syndromes D46 7 37.1 20.0 - - 42.9
  Myeloproliferaitive neoplasms D45,D47 14 77.1 2.9 - 2.9 17.1
Not included above
  Carcinoma in situ of the breast D05 43 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 119 100.0 - - - -
  Borderline tumour of the ovary D39 16 97.5 - - - 2.5
  Basal cell carcinoma of the skin 443 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.